相关实验视频

Updated: Jan 11, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

通过表面降低方法和DARPin辅助方法,波罗样类激酶1-抑制剂共同复杂结构

Uwe Eberspaecher¹, Arndt A Schmitz¹, Gerhard Siemeister²

¹Research and Development, Pharmaceuticals, Bayer AG, Muellerstrasse 178, 13353 Berlin, Germany.

Acta crystallographica. Section D, Structural biology

|November 17, 2025

概括

开发了一种用于结晶Polo样酶1 (PLK1) 的新方法,这是一个关键的癌症标,使用双重突变来降低表面. 这使得能够确定新的抑制剂结合结构,促进癌症药物发现.

科学领域:

生物化学生物化学
结构生物学结构生物学
药物发现药物发现药物发现

背景情况:

波罗样酶1 (PLK1) 是细胞分裂的关键调节剂,也是长期以来的癌症药物标.
在结构研究中,PLK1激酶域的结晶一直是重要的障碍.
之前的努力利用设计的氨酸重复蛋白 (DARPins) 来促进PLK1结晶.

研究的目的:

开发一种替代和有效的方法来结晶PLK1激酶域.
确定PLK1与各种抑制剂系列的共同复杂晶体结构.
分析和比较PLK1结晶的不同策略.

主要方法:

在PLK1中引入双重突变,以减少表面和促进晶体接触.
使用工程PLK1进行与抑制剂共复合结晶.
用X射线晶体学来确定PLK1抑制剂复合物的三维结构.

主要成果:

通过降低表面的策略,成功地实现了PLK1的结晶.
确定了与PLK1的拜耳 thiazolidinone 系列的第一个共同复杂的晶体结构.
还获得了PLK1与两个竞争对手抑制剂系列的晶体结构,揭示了它们的结合模式.

结论:

双突变方法为PLK1结晶提供了一个可行的替代方案,补充了现有的方法.
确定的结构为不同PLK1抑制剂的分子相互作用提供了关键的见解.
这项工作促进了对PLK1抑制的结构性理解,支持开发新型癌症治疗方法.

关键词:

小分子抑制剂PLK1小分子抑制剂服务服务服务服务服务服务.结晶化结晶化的过程.激酶激酶的作用是什么减少了表面的减少.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO

Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO

Published on: December 28, 2019

相关概念视频

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Coat Assembly and GTPases

Coat Assembly and GTPases

Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...

Assembly of Signaling Complexes

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...